FM
Freemont Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.9M | Buy |
20,000
+14,200
| +245% | +$6.32M | 1.33% | 23 |
|
|
2025
Q1 | $2.81M | Sell |
5,800
-600
| -9% | -$291K | 0.92% | 33 |
|
|
2024
Q4 | $2.58M | Hold |
6,400
| – | – | 1.12% | 24 |
|
|
2024
Q3 | $2.98M | Hold |
6,400
| – | – | 1.46% | 17 |
|
|
2024
Q2 | $3M | Sell |
6,400
-31,300
| -83% | -$14.7M | 1.42% | 11 |
|
|
2024
Q1 | $15.8M | Sell |
37,700
-11,700
| -24% | -$4.89M | 2.25% | 9 |
|
|
2023
Q4 | $20.1M | Hold |
49,400
| – | – | 2.53% | 10 |
|
|
2023
Q3 | $17.2M | Sell |
49,400
-8,300
| -14% | -$2.89M | 2.57% | 9 |
|
|
2023
Q2 | $20.3M | Hold |
57,700
| – | – | 2.45% | 9 |
|
|
2023
Q1 | $18.2M | Hold |
57,700
| – | – | 2.55% | 9 |
|
|
2022
Q4 | $16.7M | Buy |
57,700
+17,200
| +42% | +$4.97M | 2.61% | 9 |
|
|
2022
Q3 | $11.7M | Buy |
40,500
+19,700
| +95% | +$5.7M | 2.14% | 11 |
|
|
2022
Q2 | $5.86M | Sell |
20,800
-1,200
| -5% | -$338K | 1.01% | 40 |
|
|
2022
Q1 | $5.74M | Buy |
+22,000
| New | +$5.74M | 0.87% | 52 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 116 |
|
|
2021
Q3 | – | Sell |
-32,000
| Closed | -$6.45M | – | 113 |
|
|
2021
Q2 | $6.45M | Hold |
32,000
| – | – | 0.93% | 46 |
|
|
2021
Q1 | $6.88M | Hold |
32,000
| – | – | 1.12% | 43 |
|
|
2020
Q4 | $7.56M | Buy |
+32,000
| New | +$7.56M | 1.41% | 36 |
|